These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26821574)

  • 1. A comparison of the ability of the human IgG1 allotypes G1m3 and G1m1,17 to stimulate T-cell responses from allotype matched and mismatched donors.
    Webster CI; Bryson CJ; Cloake EA; Jones TD; Austin MJ; Karle AC; Spindeldreher S; Lowe DC; Baker MP
    MAbs; 2016; 8(2):253-63. PubMed ID: 26821574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human G1m1 allotype associates with CD4+ T-cell responsiveness to a highly conserved IgG1 constant region peptide and confers an asparaginyl endopeptidase cleavage site.
    Stickler MM; Reddy A; Xiong JM; Hinton PR; DuBridge R; Harding FA
    Genes Immun; 2011 Apr; 12(3):213-21. PubMed ID: 21326320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surprising negative association between IgG1 allotype disparity and anti-adalimumab formation: a cohort study.
    Bartelds GM; de Groot E; Nurmohamed MT; Hart MH; van Eede PH; Wijbrandts CA; Crusius JB; Dijkmans BA; Tak PP; Aarden L; Wolbink GJ
    Arthritis Res Ther; 2010; 12(6):R221. PubMed ID: 21187010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reaction of rheumatoid factors with IgG3 monoclonal anti-Rh(D) antibodies: more frequent reactivity to a monoclonal antibody of the Gm allotype G3m(5) in rheumatoid patients negative for G3m(5).
    Puttick AH; Williamson EA; Merry AH; Kumpel BM; Thompson KM; Jones VE
    Ann Rheum Dis; 1988 Nov; 47(11):898-905. PubMed ID: 3207373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 Vaccination.
    Kratochvil S; McKay PF; Chung AW; Kent SJ; Gilmour J; Shattock RJ
    Front Immunol; 2017; 8():1883. PubMed ID: 29326728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG1 heavy chain-coding gene polymorphism (G1m allotypes) and development of antibodies-to-infliximab.
    Magdelaine-Beuzelin C; Vermeire S; Goodall M; Baert F; Noman M; Assche GV; Ohresser M; Degenne D; Dugoujon JM; Jefferis R; Rutgeerts P; Lefranc MP; Watier H
    Pharmacogenet Genomics; 2009 May; 19(5):383-7. PubMed ID: 19319024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new assay uses monoclonal anti-Rh(D) antibodies to determine rheumatoid factor specificity: reactivity to a monoclonal antibody of the Gm allotype G3m(21) is more frequent in rheumatoid patients negative for G3m(21).
    Jones VE; Puttick AH; Williamson EA; Mageed RA
    Clin Exp Immunol; 1988 Mar; 71(3):451-8. PubMed ID: 3383449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope characterization of pre-existing and developing antibodies to an aglycosylated monoclonal antibody therapeutic of G1m17,1 allotype.
    Tatarewicz SM; Juan G; Swanson SJ; Moxness MS
    J Immunol Methods; 2012 Aug; 382(1-2):93-100. PubMed ID: 22609464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of mouse T lymphocyte-induced suppression of the IgG2ab allotype and T lymphocyte tolerance to IgG2ab.
    Majlessi L; Bordenave G
    Arch Immunol Ther Exp (Warsz); 2001; 49(6):407-15. PubMed ID: 11814234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG1 Allotypes Influence the Pharmacokinetics of Therapeutic Monoclonal Antibodies through FcRn Binding.
    Ternant D; Arnoult C; Pugnière M; Dhommée C; Drocourt D; Perouzel E; Passot C; Baroukh N; Mulleman D; Tiraby G; Watier H; Paintaud G; Gouilleux-Gruart V
    J Immunol; 2016 Jan; 196(2):607-13. PubMed ID: 26685205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of mycobacterium tuberculosis antigen-specific CD4
    Lee YH; Hyun YS; Jo HA; Baek IC; Kim SM; Sohn HJ; Kim TG
    Front Immunol; 2022; 13():897781. PubMed ID: 35967347
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of immune recognition in latent allotype induction and clearance. Evidence for an allotypic network.
    Yarmush ML; Sogn JA; Kern PD; Kindt TJ
    J Exp Med; 1981 Jan; 153(1):196-206. PubMed ID: 7452153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DR antigens, Gm allotypes and antiallotypes in early rheumatoid arthritis--their relation to disease progression.
    Eberhardt K; Grubb R; Johnson U; Pettersson H
    J Rheumatol; 1993 Nov; 20(11):1825-9. PubMed ID: 8308765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secukinumab, a novel anti-IL-17A antibody, shows low immunogenicity potential in human in vitro assays comparable to other marketed biotherapeutics with low clinical immunogenicity.
    Karle A; Spindeldreher S; Kolbinger F
    MAbs; 2016; 8(3):536-50. PubMed ID: 26817498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope.
    Olive M; Eisenlohr L; Flomenberg N; Hsu S; Flomenberg P
    Hum Gene Ther; 2002 Jul; 13(10):1167-78. PubMed ID: 12133270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of complement by human IgG1 and human IgG3 antibodies against the human leucocyte antigen CD52.
    Redpath S; Michaelsen T; Sandlie I; Clark MR
    Immunology; 1998 Apr; 93(4):595-600. PubMed ID: 9659234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Half-life of the maternal IgG1 allotype in infants.
    Sarvas H; Seppälä I; Kurikka S; Siegberg R; Mäkelä O
    J Clin Immunol; 1993 Mar; 13(2):145-51. PubMed ID: 8320311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human monoclonal rheumatoid factors derived from the polyclonal repertoire of rheumatoid synovial tissue: production and characterization.
    Randen I; Thompson KM; Natvig JB; Førre O; Waalen K
    Clin Exp Immunol; 1989 Oct; 78(1):13-8. PubMed ID: 2805416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire.
    Bioley G; Dousset C; Yeh A; Dupont B; Bhardwaj N; Mears G; Old LJ; Ayyoub M; Valmori D
    Clin Cancer Res; 2009 Jul; 15(13):4467-74. PubMed ID: 19531622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin G genetic variation can confound assessment of antibody levels via altered binding to detection reagents.
    Purcell RA; Aurelia LC; Esterbauer R; Allen LF; Bond KA; Williamson DA; Trevillyan JM; Trubiano JA; Juno JJ; Wheatley AK; Davenport MP; Nguyen TH; Kedzierska K; Kent SJ; Selva KJ; Chung AW
    Clin Transl Immunology; 2024; 13(3):e1494. PubMed ID: 38433763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.